secwatch.observer — SEC 8-K summary
======================================

Issuer:     Intellia Therapeutics, Inc. (NTLA)
CIK:        0001652130
Form:       8-K
Filed at:   2025-04-07T23:59:59+00:00
Accession:  0001193125-25-073904
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intellia amends bylaws to adopt majority voting for uncontested director elections
--------------------------------------------------------------------------------

- Majority vote standard adopted for uncontested director elections; plurality retained for contested elections.
- Amended bylaws include proxy solicitation procedures consistent with SEC Rule 14a-19.
- Changes effective April 3, 2025; Board approved on recommendation of governance committee.
- Other clarifying and procedural amendments also made to the bylaws.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1652130/000119312525073904/0001193125-25-073904-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1652130/000119312525073904/d901196d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-073904

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer